Nexera Medical receives formal evaluation results for Antimicrobial Activity for SpectraShield™ Plus FFP3 Antimicrobial Respirator Mask from Health Protection Agency...
November 6, 2008 - Nexera Medical's SpectraShield™ Plus FFP3 Antimicrobial Respirator Mask passes Bacteria Testing for antimicrobial efficacy. Nexera Medical received successful evaluation results for Antimicrobial Activity for SpectraShield™ Plus FFP3 Antimicrobial Respirator Mask from the Health Protection Agency, Centre for Emergency Preparedness and Response, a certified testing facility in the European Union. The Bacteria tests were performed on MS-2 coliphage, Streptococcus pyogenes, Methicillin-Resistant Staphylococcus Aureus (MRSA), Haemophilius Influenza, and Legionella pneumophila. The tests concluded that these bacteria were killed up to 99.99% in a 1 hour period. The tests, conducted over the past 3 months were designed to evaluate the SpectraShield™ Plus FFP3 mask's antimicrobial properties on a number of bacterial microorganisms to demonstrate the efficacy of our technology. Varying inoculation concentrations of 0 to 1,000,000 units were tested within a time span of 0 - 60 minutes. Results indicated that up to 99.99% (or to five log reduction) of the bacterial microorganisms were killed within one hour on some bacterial organisms.
Paul Sallarulo, President and Chief Executive Officer of Nexera Medical, states that; "This antimicrobial evaluation from the Health Protection Agency for our SpectraShield Plus FFP3 Antimicrobial Respirator Mask against bacteria is another step forward and supports our mission to become the world's leading developer and manufacturer antimicrobial respirator masks which are designed to protect people during a widespread health crisis. In addition, he states; "We endeavor to improve our product technology and marketing reach throughout the world with continued effort for additional regulatory approval in the other countries".
SpectraShield™ Plus FFP3 Antimicrobial Respirator Mask is manufactured using a patented technology; antimicrobial fibers used in the mask incorporate non-toxic silver-copper ionic agents proven safe for extended contact with individuals. Due to SpectraShield™ Plus FFP3's antimicrobial properties, the SpectraShield™ Plus FFP3 Antimicrobial Respirator Mask continuously self-sanitizes itself for extended use.
About Nexera Medical, Inc. Nexera Medical Inc. is engaged in the development, manufacturing and distribution of antimicrobial respirator and surgical masks, as well as other antimicrobial textile based medical products such as medical slings, surgical site aprons and hospital linen products worldwide. The company's mission is to create high-quality, cutting-edge health related medical products designed to safeguard and enhance the quality of human life. All of Nexera's products are designed to provide maximum protection against microorganisms such as bacteria, virus and fungus using Fosshield® patented technology. Nexera partners with governments and leaders in the health care industry in the fight against viral pandemic and other healthcare crises. For more information, visit www.nexeramed.com.
SpectraShield™ Plus FFP3 is a registered trademark of Nexera Medical, Inc.